Dutasteride-Based Topical Compositions for Specialized Environments and Skin Types

Publication ID: 24-11857556_0009_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Dutasteride-Based Topical Compositions for Specialized Environments and Skin Types,” Published Technical Disclosure No. 24-11857556_0009_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857556_0009_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,556.

Summary of the Inventive Concept

The present invention relates to novel topical compositions of dutasteride adapted for specific, niche environments and skin types, addressing the limitations of existing hair growth and loss prevention solutions.

Background and Problem Solved

The original patent disclosed compositions for topical application for preventing hair loss and stimulating hair growth comprising 5α-reductase inhibitors, especially dutasteride. However, these compositions may not be suitable for unique operational environments or skin types, such as high-altitude, disaster relief, or extreme weather conditions. The present inventive concept addresses these limitations by adapting the dutasteride-based compositions for these specialized scenarios.

Detailed Description of the Inventive Concept

The new inventive concept encompasses a range of dutasteride-based topical compositions designed for specific, niche environments and skin types. Claim 1 discloses a method for preventing hair loss in high-altitude environments, where the composition is adapted for high-altitude skin conditions. Claim 2 describes a system for stimulating hair growth in areas affected by natural disasters, utilizing a specialized delivery vehicle designed to penetrate damaged skin. Claim 3 presents a composition for topical administration in extreme weather conditions, packaged in a portable, waterproof container. Claim 4 outlines a method for treating androgenic alopecia in individuals with sensitive skin, using a soothing agent to minimize irritation. Finally, Claim 5 reveals a topical composition for preventing hair loss in high-humidity environments, adapted to maintain skin health in humid conditions. These compositions and methods address the specific challenges and requirements of these specialized scenarios, providing effective solutions for hair growth and loss prevention.

Novelty and Inventive Step

The novelty of the present inventive concept lies in the adaptation of dutasteride-based compositions for specific, niche environments and skin types, which was not disclosed in the original patent. The inventive step involves the recognition of the need for specialized formulations and delivery systems for these unique scenarios, and the development of novel compositions and methods that address these specific challenges.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may include adapting the compositions for other specialized environments, such as desert or tropical conditions, or for specific skin conditions, such as acne-prone or aging skin. Variations may also include different delivery vehicles, such as transdermal patches or sprays, or the use of other 5α-reductase inhibitors.

Potential Commercial Applications and Market

The present inventive concept has significant commercial potential in the hair care and dermatology industries, particularly in niche markets catering to individuals with specific skin types or operating in unique environments. Target industries may include high-altitude or extreme weather expedition companies, disaster relief organizations, or specialty dermatology clinics.

Field of Art

Pharmaceutical formulations, specifically topical compositions for hair loss treatment and dermatological applications involving 5α-reductase inhibitors

Person of Ordinary Skill (PHOSITA) Profile

A pharmaceutical formulation scientist or dermatological researcher with expertise in drug delivery systems, excipient selection, and topical composition design, holding at least a Master's degree with practical experience in developing transdermal and topical drug formulations

Obviousness Rationale

A person having ordinary skill in the art would recognize that the source patent's dutasteride composition provides a foundational framework for adapting the formulation to specific environmental and physiological conditions. The PTD's variations represent predictable extensions of known pharmaceutical design principles, involving routine optimization of excipients, delivery mechanisms, and concentration ranges. The core active ingredient (dutasteride) remains consistent, with modifications focusing on enhancing penetration, stability, and patient-specific adaptability.

Obvious Combinations & Variations

Source Patent Element
Topical composition with 0.056 wt% dutasteride and specific carrier oils
PTD Variation
Adapting composition for high-altitude or extreme weather environments by modifying excipient blend
Obviousness Reasoning
Routine pharmaceutical formulation optimization involving known techniques for adjusting carrier systems to accommodate environmental variables
Source Patent Element
Medium chain triglycerides as a base carrier
PTD Variation
Introducing specialized delivery vehicles for penetrating damaged skin in disaster areas
Obviousness Reasoning
Predictable application of known transdermal drug delivery principles to enhance penetration through modified carrier systems
Source Patent Element
Topical hair loss treatment composition
PTD Variation
Adding protective agents like UV-protectants or antifungal components for specific environmental conditions
Obviousness Reasoning
Well-established pharmaceutical practice of incorporating protective excipients to enhance formulation stability and efficacy
Source Patent Element
Base dutasteride composition for hair loss treatment
PTD Variation
Developing compositions for sensitive skin with added soothing agents
Obviousness Reasoning
Conventional pharmaceutical approach of modifying formulations to improve patient tolerability through known excipient selections
Source Patent Element
Fixed concentration of dutasteride in topical composition
PTD Variation
Slight variations in dutasteride concentration (0.2-0.4 mg) for different skin conditions
Obviousness Reasoning
Predictable pharmaceutical design involving routine concentration adjustments within established therapeutic ranges
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857556 and the disclosed variations, a person having ordinary skill in the art would find the claimed topical dutasteride compositions obvious through routine pharmaceutical formulation techniques. The present publication demonstrates that adapting the base composition to specific environmental and physiological conditions represents predictable variations within the ordinary skill of a formulation scientist, thereby rendering potential derivative claims obvious and anticipatable.

Original Patent Information

Patent NumberUS 11,857,556
TitleTopical compositions of dutasteride
Assignee(s)SHILPA MEDICARE LIMITED